It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PFE’s FA Score shows that 0 FA rating(s) are green whileSWK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PFE’s TA Score shows that 3 TA indicator(s) are bullish while SWK’s TA Score has 4 bullish TA indicator(s).
PFE (@Pharmaceuticals: Major) experienced а -3.94% price change this week, while SWK (@Industrial Machinery) price change was -2.64% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +1.01%. For the same industry, the average monthly price growth was -0.04%, and the average quarterly price growth was +10.01%.
The average weekly price growth across all stocks in the @Industrial Machinery industry was -0.04%. For the same industry, the average monthly price growth was +7.31%, and the average quarterly price growth was +9.30%.
PFE is expected to report earnings on Nov 04, 2025.
SWK is expected to report earnings on Oct 23, 2025.
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
@Industrial Machinery (-0.04% weekly)The industry makes and maintains machines for consumers, the industry, and most other companies. While it has traditionally been categorized as heavy industry, some smaller companies are also branching into the light category. The industry is pivotal in providing the equipment for production in businesses like agriculture, mining, industry and construction, gas, electricity and water utilities. It also supplies supporting equipment for almost all sectors of the economy, such as equipment for heating, and air conditioning of buildings. Illinois Tool Works Inc., Parker-Hannifin Corporation and Rockwell Automation Inc are some of the major U.S. companies operating in this industry.
PFE | SWK | PFE / SWK | |
Capitalization | 157B | 15.1B | 1,040% |
EBITDA | 9.56B | 809M | 1,181% |
Gain YTD | -3.905 | -11.069 | 35% |
P/E Ratio | 74.92 | 81.30 | 92% |
Revenue | 58.5B | 15.8B | 370% |
Total Cash | 12.7B | 449M | 2,829% |
Total Debt | 70.8B | 7.31B | 969% |
PFE | SWK | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 69 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 50 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 53 | 51 | |
P/E GROWTH RATING 1..100 | 100 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PFE's Valuation (50) in the Pharmaceuticals Major industry is in the same range as SWK (50) in the Tools And Hardware industry. This means that PFE’s stock grew similarly to SWK’s over the last 12 months.
PFE's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as SWK (100) in the Tools And Hardware industry. This means that PFE’s stock grew similarly to SWK’s over the last 12 months.
PFE's SMR Rating (100) in the Pharmaceuticals Major industry is in the same range as SWK (100) in the Tools And Hardware industry. This means that PFE’s stock grew similarly to SWK’s over the last 12 months.
SWK's Price Growth Rating (51) in the Tools And Hardware industry is in the same range as PFE (53) in the Pharmaceuticals Major industry. This means that SWK’s stock grew similarly to PFE’s over the last 12 months.
SWK's P/E Growth Rating (100) in the Tools And Hardware industry is in the same range as PFE (100) in the Pharmaceuticals Major industry. This means that SWK’s stock grew similarly to PFE’s over the last 12 months.
PFE | SWK | |
---|---|---|
RSI ODDS (%) | 1 day ago65% | 1 day ago59% |
Stochastic ODDS (%) | 1 day ago60% | 1 day ago60% |
Momentum ODDS (%) | 1 day ago55% | 1 day ago67% |
MACD ODDS (%) | 1 day ago63% | 1 day ago67% |
TrendWeek ODDS (%) | 1 day ago61% | 1 day ago69% |
TrendMonth ODDS (%) | 1 day ago52% | 1 day ago68% |
Advances ODDS (%) | 13 days ago56% | 6 days ago64% |
Declines ODDS (%) | 1 day ago61% | 1 day ago72% |
BollingerBands ODDS (%) | 1 day ago55% | 1 day ago68% |
Aroon ODDS (%) | 1 day ago54% | 1 day ago69% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PGRO | 41.39 | 0.18 | +0.44% |
Putnam Focused Large Cap Growth ETF | |||
LRND | 36.84 | N/A | N/A |
NYLI U.S. Large Cap R&D Leaders ETF | |||
SEPM | 30.87 | -0.04 | -0.14% |
FT Vest U.S. Eq Max Buffr ETF - Sep | |||
FCAL | 47.79 | -0.07 | -0.15% |
First Trust California Muni Hi Inc ETF | |||
FTCB | 20.79 | -0.07 | -0.34% |
First Trust Core Investment Grade ETF |
A.I.dvisor indicates that over the last year, PFE has been loosely correlated with GSK. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if PFE jumps, then GSK could also see price increases.
Ticker / NAME | Correlation To PFE | 1D Price Change % | ||
---|---|---|---|---|
PFE | 100% | -2.92% | ||
GSK - PFE | 60% Loosely correlated | -1.23% | ||
AMGN - PFE | 58% Loosely correlated | -1.52% | ||
ABBV - PFE | 56% Loosely correlated | -1.84% | ||
NVS - PFE | 54% Loosely correlated | -1.13% | ||
BMY - PFE | 53% Loosely correlated | -1.92% | ||
More |
A.I.dvisor indicates that over the last year, SWK has been closely correlated with NDSN. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if SWK jumps, then NDSN could also see price increases.
Ticker / NAME | Correlation To SWK | 1D Price Change % | ||
---|---|---|---|---|
SWK | 100% | -2.49% | ||
NDSN - SWK | 72% Closely correlated | -1.62% | ||
ITW - SWK | 69% Closely correlated | -0.49% | ||
DCI - SWK | 68% Closely correlated | -0.61% | ||
HLMN - SWK | 68% Closely correlated | -3.09% | ||
GGG - SWK | 67% Closely correlated | -1.38% | ||
More |